All Curated Mutation Sites in HCV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HCV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
5'UTR
  
C
  
E1
  
E2
  
NS2
  
NS3
  
NS4B
  
NS5A
  
NS5B
  
p7
  
Protease
  

Keyword: HCV Infection-19302336
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 19302336 C281A
E2
E2
HCV Infection
G
View
2 19302336 G278A
E2
E2
HCV Infection
G
View
3 19302336 G278P
E2
E2
HCV Infection
G
View
4 19302336 L271A
E2
E2
HCV Infection
G
View
5 19302336 L280V
E2
E2
HCV Infection
G
View
6 19302336 C281P
E1
E1
HCV Infection
G
View
7 19302336 G282A
E1
E1
HCV Infection
G
View
8 19302336 L271F
E1
E1
HCV Infection
G
View
9 19302336 L271P
E1
E1
HCV Infection
G
View
10 19302336 L280A
E1
E1
HCV Infection
G
View
11 19302336 L280P
E1
E1
HCV Infection
G
View
12 19302336 L286P
E1
E1
HCV Infection
G
View
13 19302336 E188K HCV Infection
G
View
14 19302336 F186L HCV Infection
G
View
15 19302336 G282P HCV Infection
G
View
16 19302336 I348S HCV Infection
G
View
17 19302336 L286A HCV Infection
G
View
18 19302336 Q1251L HCV Infection
G
View
19 19302336 R259A HCV Infection
G
View
20 19302336 R259E HCV Infection
G
View
21 19302336 R296A HCV Infection
G
View
22 19302336 R296E HCV Infection
G
View
23 19302336 S268P HCV Infection
G
View
24 19302336 S283P HCV Infection
G
View
25 19302336 Y361H HCV Infection
G
View
Contents
Description

The table shows all curated mutation sites of HCV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.